Douglas Ingram

Douglas S.
Ingram is Chief Executive Officer & Director at Sarepta Therapeutics, Inc. since 2026.
He is a Director at Allergan Foundation.
He is an Independent Director at Relay Therapeutics, Inc. since 2019.
Formerly, Mr. Ingram was President, Chief Executive Officer & Director at Chase Pharmaceuticals Corp.
from 2015 to 2016.
He was Vice Chairman at Skye Bioscience, Inc. from 2015 to 2018.
He served as Director at Arrowhead Pharmaceuticals, Inc. from 2025 to 2026.
He was Director at Pacific Mutual Holding Co. from 2015 to 2018.
He was Director at ECC Capital Corp.
and Volcom, Inc. He was Director at Endo International Plc from 2016 to 2017.
He was Director at Pacific Life Insurance Co. He was President at Allergan, Inc. from 2013 to 2015.
He worked as an Attorney at Gibson, Dunn & Crutcher, Inc. from 1988 to 1996.
Mr. Ingram completed undergraduate studies at Arizona State University in 1985 and graduate studies at the University of Arizona in 1988.